Prosiectau (2906)
Cardiff University Schools involved in this Project
Validation of nWASP (neural Wiskott-Aldrich Syndrome Protein) as a therapeutic target in chronic non-healing human wounds (01.01.2014 - 31.12.2016)
- Jiang, Wen
Validation of a novel adapted qSOFA score to predict death in Malawian children with suspected infection (01.06.2020 - 31.07.2020)
- Pallmann, Philip
Validation of an improved synthesis of 18F-Flumazenil (01.08.2020 - 31.10.2021)
- Marshall, Christopher
Validation of a new AI solution to predict relapse at 5-10 years on histology slides in early breast cancer patients (01.03.2024 - 28.02.2026)
- Parry-Jones, Alison
Validation and use of a model system to investigate topical treatment of vulval intraepithelial neoplasia (01.01.2010 - 15.01.2013)
- Powell, Ned
Validating prognostic biomarkers for colorectal cancer and determining their clinical utility (01.11.2018 - 30.09.2024)
- Cheadle, Jeremy
Utilising proteomics to develop anti-HCMV immunotherapy (31.01.2014 - 30.09.2017)
- Stanton, Richard
Utilising data linkage to investigate the health impact of carrier status for common genetic disorders (02.01.2023 - 31.12.2025)
- Fry, Andrew
Utilising adoption-based research designs to examine the interplay between family relationships processes and child developmental outcomes (01.01.2015 - 27.01.2017)
- Thapar, Anita
Ustekinumab in adolescents with recent-onset type 1 diabetes (USTEKID) (01.11.2017 - 31.12.2023)
- Dayan, Colin
Using whole exome sequencing to identify genetic modifiers of Huntington's disease (01.09.2017 - 31.07.2019)
- Jones, Aileen Lesley
Using wearable technology to predict per-operative outcomes (01.09.2016 - 31.08.2017)
- Busse-Morris, Monica
Using the smartphone to monitor mood states (01.08.2015 - 30.11.2016)
- Linden, David
Using subcellular quantitative proteomics to analyse CLL cells (01.07.2010 - 31.01.2014)
- Brennan, Paul
Using structural studies of T-cell receptors (TCRs) bound to peptide-MHC class II (pMHC-II) to inform COVID-19 vaccine design (05.08.2020 - 06.06.2021)
- Godkin, Andrew
Using spatial-transcriptomics to define gene expression profile of SEGAs in Tuberous Sclerosis Complex (01.12.2021 - 30.11.2022)
- Williams, Hywel
Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders - REALMENT (01.06.2021 - 31.05.2025)
- Walters, James
Using patient derived gastric cancer organoids to identify which patients will respond to different chemotherapeutic regimens based on molecular subtype (01.02.2019 - 31.08.2020)
- Powell, Arfon
Using injectable end-of-life symptom control medications at home: understanding human and system factors through inclusive design (16.01.2023 - 15.01.2027)
- Carson-Stevens, Andrew
- Using genetics, neurophysiology and longitudinal data to disentangle the complex relationship between sleep and mood disorders
(01.01.2023 - 30.09.2025)- Lewis, Katie Lewis
Using genetics, neurophysiology and longitudinal data to disentangle the complex relationship between sleep and mood disorders (01.10.2021 - 30.09.2025)
- Lewis, Katie Lewis
- Using genetic modifiers to investigate the molecular mechanisms of repeat expansion in Huntington’s disease
(01.10.2021 - 31.03.2023)- Massey, Thomas
Using genetic modifiers to investigate the molecular mechanisms of repeat expansion in Huntington’s disease (01.09.2021 - 31.03.2023)
- Massey, Thomas
Using genetic modifiers to identify and target pathogenic mechanisms in Huntington's disease (01.08.2023 - 31.07.2028)
- Massey, Thomas
Using cytokines to define biomarkers and therapeutic targets in rheumatoid arthritis (01.10.2015 - 30.09.2018)
- Jones, Gareth
Using CRISPR/Cas9 tools for the engineering of ureaplasma spp. cloned into yeast (01.05.2017 - 31.12.2019)
- Spiller, Brad
Using CRISPR-Cas13 to restore function in Huntington’s disease neurons. (01.07.2023 - 31.08.2024)
- Dion, Vincent
Using computer based cognitive training to provide a personalised therapeutic intervention for people with Huntingtons disease (01.10.2016 - 30.09.2019)
- Busse-Morris, Monica
Using a smartphone app. Cardiff arthritis realtime evaluator (CARE) to promote self assessment of disease activity by patients with Rheumatoid Arthritis - level 2 review (01.05.2012 - 31.03.2016)
- Choy, Ernest
Using antibodies as templates to develop small molecule anti-complement drugs to deliver to Alzheimer’s brain (03.10.2022 - 02.10.2025)
- Zelek, Wioleta
Using a health coaching approach with people with progressive neurological conditions (25.09.2017 - 31.05.2018)
- Davies, Freya
Use of the dictionary in palliative care to establish incidence and prevalence of life-limiting condition in childhood (DicData) (01.09.2010 - 15.07.2014)
Use of technological platforms to enhance phenotypic understanding in primary dystonia (01.07.2019 - 01.05.2023)
- Peall, Kathryn
Use of technological platforms to enhance phenotypic understanding in primary dystonia (01.08.2019 - 31.07.2022)
- Peall, Kathryn
Use of MRD negative CR as an endpoint reasonably likely to predict benefit in subjects with newly diagnosed NPM1-mutated AML (23.09.2021 - 30.04.2024)
- Thomas, Ian
Use of microarray to identify the mechanism of developmental disruption induced by over-expression of g-catenin in AML (01.02.2008 - 31.07.2009)
- Tonks, Alex
Use of bacteriophages to reduce the carrier state and the rate of nosocomial infections with multi-resistant Gram-negative bacteria (01.02.2012 - 31.12.2015)
- Toleman, Mark
Urine exosomes: a source of novel disease biomarkers in bladder cancer (21.08.2006 - 28.02.2010)
- Clayton, Aled
Urinary stones and intervention quality of life (USI - Qol) - Validation of a new universal patient reported outcome measure (PROM) (01.07.2018 - 31.07.2019)
- Pickles, Timothy
U-RHYTHM: A powerful research tool for studies on human rhythms in health and disease (01.06.2022 - 31.05.2024)
- Jones, Simon
Unrecognised bipolar spectrum disorders in primary care patients with depression 2 (01.04.2008 - 31.08.2010)
Unrecognised bipolar spectrum disorders in primary care patients with depression (01.04.2008 - 31.08.2010)
Unravelling the relationship between T-cell trafficking and cancer immunotherapy (01.09.2017 - 31.12.2021)
- Ager, Ann
Unravelling the molecular basis of the association of genetic variation in the clusterin gene with risk of Alzheimer's disease (01.10.2020 - 30.09.2023)
- Morgan, Paul
Unravelling the molecular basis of the association of genetic variation in the clusterin gene with risk of Alzheimer's disease (01.10.2020 - 31.12.2024)
- Sims, Rebecca
Unmet needs of families in Wales affected by sudden arrhythmic death syndrome (01.06.2008 - 31.07.2010)
- Brain, Katherine
United Kingdom lung cancer screening trial (UKLS) - pilot (01.04.2011 - 31.03.2015)
- Brain, Katherine
Understanding the variaion of modern endoscopic ultrasound use in patients with oesophageal cancer (VALUE): A multi-methods study (01.10.2023 - 01.07.2026)
- Foley, Kieran
Understanding the shared decision making encounter: A mixed-methods evaluation of patients and clinicians of MAGIC (22.10.2013 - 30.11.2016)
- Brain, Katherine
Understanding the scale and nature of avoidable harm in prison healthcare (01.06.2019 - 30.11.2023)
- Edwards, Adrian
- Understanding the role of secondary school environments and policies as drivers of
school connectedness to prevent anxiety and depression (22.08.2022 - 12.05.2024)- Segrott, Jeremy
Understanding the role of parents in paediatric safety incidents in general practice: mixed methods study to develop harm reduction strategies (01.04.2023 - 31.08.2024)
- Purchase, Thomas
Understanding the role of AD endocytic risk genes in disease pathogenesis. (01.01.2024 - 31.12.2026)
- Connor-Robson, Natalie
Understanding the risk profiles and outcomes of Welsh patients with a diagnosis of acute coronary syndrome (01.07.2015 - 30.06.2016)
- Freeman, Phillip
Understanding the relationship between pre-exposure prophylaxis, sexually transmitted infections and antimicrobial resistance in wales (UNREST) (01.10.2019 - 01.04.2023)
- Hood, Kerenza
Understanding the relationship between fibrin amyloid microclots and Long Covid. (01.04.2023 - 31.03.2024)
- Price, David
Understanding the proteome of the early endosome in alzheimer's disease (01.02.2023 - 31.12.2024)
- Connor-Robson, Natalie
Understanding the nature and frequency of avoidable harm in primary care (01.04.2015 - 31.12.2017)
- Carson-Stevens, Andrew
Understanding the molecular conversation between prostate cancer cells and T cells to improve immunotherapy (01.12.2021 - 31.08.2023)
- Man, Stephen
Understanding the modulation of the innate immune system by MCR-producing enterobacteriaceae during infection (01.04.2019 - 31.03.2020)
- Walsh, Timothy
Understanding the mechanisms of sedation: Effects of GABAergic and non GABAergic sedatives on magnetoencephalographic visual gamma responses (01.08.2013 - 31.07.2014)
- Hall, Judith
Understanding the mechanisms by which C3 nephritic factor causes renal disease: correlation of function with phenotype (01.01.2009 - 30.04.2010)
- Harris, Claire
Understanding the interplay between APOE and BIN1 in the molecular mechanisms of late onset Alzheimer’s Disease (01.10.2022 - 30.09.2025)
- Williams, Julie
Understanding the interplay between APOE and BIN1 in molecular mechanisms of late onset Alzheimer’s Disease (11.07.2022 - 10.07.2025)
- Williams, Julie
Understanding the impact of telomere dysfunction on the evolving cancer genome (01.04.2020 - 31.03.2026)
- Baird, Duncan
Understanding T cell migration in inflamed endothelium in Diabetes Type 1 (01.05.2013 - 30.04.2014)
- Wong, Susan
Understanding Quality of Life and Correlates of Clinical Outcome in High Risk MDS patients undergoing cytotoxic chemotherapy (QoLCO-MDS) (01.06.2022 - 31.05.2024)
- Thomas, Ian
Understanding primary care perspectives on prescribing antibiotics for skins and soft tissue infections (01.07.2012 - 31.08.2014)
Understanding pathogenic and regulatory B cells in type 1 diabetes (01.04.2013 - 30.09.2016)
- Wong, Susan
Understanding molecular controls of tissue resident macrophages (15.02.2016 - 14.02.2023)
- Taylor, Philip
Understanding microglial dysfunction in Alzheimer’s disease through rare coding variants (01.10.2021 - 30.09.2024)
- Taylor, Philip
Understanding mechanisms of thrombosis and thrombocytopenia in COVID-19 and with SARS-CoV-2 vaccines (01.07.2021 - 28.02.2023)
- Parker, Alan
Understanding mechanisms of NFIC in regulating AML development and progression (01.10.2022 - 30.09.2025)
- Tonks, Alex
Understanding healthcare utilisation of responders and non-responders to the bowel screening programme in Wales (01.01.2012 - 31.05.2014)
- Dunstan, Frank
Understanding experience, completion and outcomes of colorectal cancer screening among participants with multi-morbidity (01.10.2018 - 31.01.2024)
- Smits, Stephanie
Understanding ectopic lymphoid structure development in the inflamed synovium - evaluating the prognostic and therapeutic potential of IL-27 (01.07.2013 - 31.12.2019)
- Jones, Gareth
Understanding barriers to breastfeeding: A socio-ecological understanding of infant feeding within public space using participatory visual and ethnographic methods to facilitate future intervention development (09.10.2017 - 26.09.2019)
- Grant, Aimee
Understanding aspects of cardiovascular disease via a multi-physics modelling methodology (01.10.2014 - 30.09.2017)
- Parthimos, Dimitris
Understanding and applying immune-modulation mechanisms by chronic pathologens to human pathology and disease (15.07.2013 - 31.08.2014)
- Jones, Simon
Understanding adverse mental health outcomes in children born with cleft lip and/or palate using genetics . MRC neurosciences and mental health research grant (01.09.2022 - 31.08.2025)
- van den Bree, Marianne
Uncovering the mechanisms involved in the block of Ca2+ release from the cardiac sarcoplasmic reticulum by flecainide (01.01.2012 - 30.06.2014)
- Williams, Alan
Uncovering metabolic errors in foetal brain development through advanced lipid imaging (01.09.2020 - 31.12.2021)
- Mire, Erik
Ulipristal acetate versus conventional management of heavy menstrual bleeding (HMB; including uterine fibroids): A randomised controlled trial and exploration of mechanism of action (UCON trial) (01.05.2018 - 30.09.2018)
- Bhattacharya, Siladitya
UKT1D-RC Request for Support 2023-2025 (01.12.2023 - 01.11.2024)
- Dayan, Colin
UKT1D-RC - Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger, smarter, faster (01.05.2019 - 30.11.2025)
- Dayan, Colin
UKRI FLF Development network (15.10.2020 - 31.12.2023)
- Hood, Kerenza
UKRI-COA: UK Consortium for MetAbolic Phenotyping (MAP UK) (01.04.2021 - 31.07.2021)
- O'Donnell, Valerie
UKRI-COA The role of antibody in enabling cell-mediated control of HCMV infection (01.04.2021 - 30.09.2021)
- Stanton, Richard
UKRI-COA: The regulation of protective immunity to viruses by L-selection (01.04.2021 - 30.09.2021)
- Ager, Ann
UKRI-COA: Molecular regulation of necroptosis in inflammatory diseases (01.04.2021 - 30.09.2021)
- Bonnet, Marion
UKRI CoA: Investigating the inter-relationship between diabetes and children's educational achievement (21.11.2020 - 30.04.2021)
- French, Robert
UKRI COA: Investigating genetic and environmental risk for psychosis mediated through l-type voltage gated calcium channels (01.04.2021 - 30.09.2021)
- Hall, Jeremy
UKRI CoA: How does GG-NERC complex-dependent chromatin remodelling initiate DNA damage recognition in chromatin by the Rad4-Rad23 damage recognition complex (31.12.2020 - 30.09.2021)
- Reed, Simon
UKRI CoA: Framing the trajectories of decision-making in the context of predictive and prenatal genetic and genomic tests (31.01.2021 - 31.07.2021)
- Clarke, Angus
UKRI-COA: Eosinophil and macrophage crosstalk defines cells survival and modulates local tissue niche (01.04.2021 - 30.09.2021)
- Czubala, Magdalena
UKRI CoA: Early-onset depression: Characterising development and identifying risks (20.11.2020 - 30.09.2021)
- Rice, Frances
UKRI CoA: Determining the mechanisms of striatal dysfunction in SGCE mutation positive myoclonus dystonia using an iPSC-derived neuronal cell model (31.03.2021 - 31.12.2021)
- Peall, Kathryn
UKRI-COA: Can microbiota modulate circadian oscillations to alter susceptibility to autoimmunity?. (01.04.2021 - 30.09.2021)
- Pearson, James
UK NCRN LI-1 trial (01.04.2012 - 31.12.2018)
- Ottmann, Oliver
UK lung cancer screening trial (UKLS) (01.04.2011 - 28.02.2013)
- Brain, Katherine